Blueprint

— Blueprint Medicines to host investor conference call and webcast on Friday, April 8, 2022 — CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced plans to present new clinical and preclinical data for multiple programs across its precision therapy portfolio at the American Association […]